4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-020260
Chief Executive Officer gave up 5,526 shares (to pay taxes)
- Chief Executive Officer acquired 11,833 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2021-03-10 | Option exercise | +11,833 | 194,024 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2021-03-10 | Shares withheld for taxes | −5,526 | $124.15 | $686,053 | 188,498 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2021-03-11 | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2021-03-11 | Grant or award · Restricted Stock Units | +36,000 | 36,000 | D | ||
Loading xslF345X03/doc4.xml…